Search the Newsroom
Filter By
Showing 2531 - 2540 of 2985 results
Children’s Hospital of Philadelphia Selected to Participate in Nationwide ‘BUILD Health Challenge'
A two-year grant will bring together community organizations to help children with asthma in West Philadelphia.
Teaching, Learning, Growing: A Global Health Journey
A week-long trip to the Dominican Republic offers CHOP staffers new avenues to improve pediatric healthcare.
Getting to and from School: The Real Safety Risk
If your child walks to school or rides a bus, this is a time to teach or remind your child about important safety rules.
High Cholesterol Can Be a Danger for Kids, Too
Risks for high cholesterol can start in childhood, so children between the ages of 9 and 11 should be screened for high cholesterol.
CHOP Clinicians Present at National Down Syndrome Congress
Three CHOP clinicians presented at the National Down Syndrome Congress in July 2017, sharing new tools to help young children and older teens with Down syndrome.
World View: Care in the Dominican Republic
At the Down Syndrome Medical Interest Group, USA (DSMIG-USA) symposium, CHOP presented on the global reach of the Trisomy 21 Program and how it helped a young boy with Down syndrome in the Dominican Republic.
Philly Eagles Take Flight for Autism Research
The Eagles held their second annual Taking Flight for Autism event Aug. 30 at Lincoln Financial Field in Philadelphia.
FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children’s Hospital of Philadelphia
This is a game changer for the treatment of pediatric patients battling leukemia and a pivotal milestone in this new era of cellular therapies that treat cancer with a patient’s own immune system.
Director of CHOP’s Lactation Program Chosen for Congressional Task Force
Dr. Spatz will help guide research specific to understanding medication risks in pregnant and lactating women.
Research May Lead to First Drug Treatment for a Disabling Bone Disease
A CHOP researcher finds that a drug candidate that blocks abnormal protein signals may yield a novel therapy for a pediatric bone disease.